Navigation Links
Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
Date:1/1/2008

WESTCHESTER, Ill. A study published in the January 1 issue of the journal SLEEP finds that zolpidem extended-release 12.5 mg, taken three to seven nights per week for up to six months, provided sustained and significant improvements in sleep onset and maintenance, and also improved next-day concentration and morning sleepiness in people with insomnia.

The study focused on 1,018 patients between 18 and 64 years of age with chronic primary insomnia, who had difficulty initiating or maintaining sleep or experiencing non-restorative sleep for three months or greater. The subjects took either a single dose of zolpidem extended-release or a placebo from three to seven nights per week.

According to the results, there was a statistically significantly greater benefit in the zolpidem group than in the placebo group on patient global ratings of improvement, with no reduction in clinical efficacy over the course of the study and no evidence of rebound insomnia upon drug discontinuation. At the 12-week end point, 89.7 percent of zolpidem extended-release patients reported that the medication helped them sleep, compared with 51.4 percent of placebo patients.

"Approximately 10 percent of the population suffers from chronic insomnia. These individuals are most commonly treated with medications in clinical practice, though for many years we lacked data on the long-term medication management of insomnia, said Andrew D. Krystal, MD, of Duke University, lead author of the study. However, recent studies document the efficacy and safety of nightly treatment with some insomnia agents for periods of up to one year. As the duration of treatment increases, the costs and risks of adverse effects associated with taking a medication nightly become increasingly important considerations. For the chronic insomnia patients who have waxing and waning symptom severity, it may be possible to decrease the costs and risks by employing non-nightly medication dosi
'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Nov. 30 Tyco Internati...2010 annual general meeting of shareholders will b...entral European time at the Park Hyatt Zurich Hote... Registered shareholders as of January 11, 2010 (t...nual general meeting. Additionally, individuals w...
(Date:11/30/2009)...30 The Eject Helmet Removal System...ment in the Top Fuel, Funny Car, Pro Stock Car and...Rod Association (NHRA) Full Throttle Drag Racing S... Alcohol Funny Car drivers in the NHRA Lucas Oil D...t allows medical caregivers at race tracks and els...
(Date:11/30/2009)...een the registration of a visual stimulus by the u...t ― between the time we see an apple and the...ehind our eyes, but by how long? And how does this... Some estimates say the time delay lasts only 100...study by Tel Aviv University psychologists says th...
(Date:11/30/2009)...8213; Providing free medications to people after h...a relatively low cost for provincial governments, ...hael,s Hospital in Toronto. , "Many patients ar...ions because they simply don,t fill their prescrip...thor and a physician at St. Michael,s Hospital. "T...
(Date:11/30/2009)...t results in animals , , MONDAY, Nov. ...suggest that stem cells from transplanted human-de...ung and heart disorders. , Scientists already ... long list of different kinds of cells in the labo...enter in Seoul, Korea, co-author of one of the stu...
Breaking Medicine News(10 mins):Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:Now you see it, now you know you see it 2Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2
...redictable influenza season returns in the fall, h...ning threat of the H1N1 outbreak may worsen. Opera...rly one-third of companies do not have a policy wh...ng Workforce Issues during a Flu-Like Pandemic." ...
...reases Low-end of EPS Guidance , , , WARSAW, In... , , , Revenue of $101.4 million, comp...rrency basis , Gross margin of 24.2%, up 7...ear and up 18.2% over the fourth quarter of 2008 ...
...3-9, 2009 , , , WASHINGTON , May 7 During Bu...undation is providing a Daily Dose of news consume..., , (Photo: http://www.newscom.com/cgi-bin/prn...to the enforcement of our nation,s safe water code...
...poration, (Nasdaq: QGLY ) , www.quigleyco.c...ter to stockholders urging them to reelect its exp...y voting the WHITE proxy card by telephone, Intern...ual Meeting of Stockholders, the Company noted the...
...tical Industry Ltd. (Nasdaq: SHMR ) (" Shamir ")...gs results on Thursday, May 14th, 2009, and has sc...t 11:00 A.M. EDT that morning. , , The conferenc... call is scheduled to begin. You will need to regi...
...ncreasing Funding for FDA, Creating a Workable Pat...erics , , ARLINGTON, Va., May 7 The Generic ...he results of an independent analysis commissioned...em more than $734 billion in the last decade (1999...
Other Medicine News:Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 2Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 4Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 5Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 6Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 7Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 8Health News:Daily Dose: Safe Water News You Can Use 2Health News:Daily Dose: Safe Water News You Can Use 3Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 2Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 3Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 4Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 5Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 6Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 7Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 8Health News:The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts 9Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter of 2009 Earnings Results 2Health News:Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade 2Health News:Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade 3Health News:Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade 4
(Date:11/30/2009)... , CHICAGO, Nov. 30 Minimall...ore costly open surgery, particularly in oncology,... a global market for image-guided navigation expec...embracing the advantages offered by minimally-inva...y times, greater patient comfort and faster patien...
(Date:11/30/2009)..., WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswire/...al Meeting of the Radiological Society of North ...nc. announced the enrollment of the first patient ...aluate the efficacy and safety of florbetaben (BAY...loid plaques in the brain, which are a pathologica...
(Date:11/30/2009)... , TEL AVIV, Israel, November 30 /PRNewsw...f the FOMRI-III(TM) dual channel microphone, the m...in functional magnetic resonance imaging,(fMRI) en...represents a major step forward for fiber,optic mi... quality ever, with,low-latency adaptive noise can...
Breaking Medicine Technology:Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 1Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 2Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 3Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 4Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 5Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 6Cardinal Health Announces 241 2 Billion Debt Tender Offer 55493 7GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 1GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 2GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 3Over 60 Firms Confirmed to Attend CBIs Third Annual Bio Pharmaceutical Collaboration and Transaction Accounting Conference in September 13715 1Over 60 Firms Confirmed to Attend CBIs Third Annual Bio Pharmaceutical Collaboration and Transaction Accounting Conference in September 13715 2
Attain LV Leads
Hancock® Standard Mitral Bioprosthesis
Vitality DS VR
...pact, portable ultrasound system which connects vi...mputer. The large display allows the entire scan t...he need for scrolling and changing back and forth ...the A-Scan 100 include built-in algorithms for dif...
Medicine Products: